Opportunity

DIBBS #SPE2DP-26-T-4480

DLA Solicitation for Verapamil Hydrochloride Extended-Release Tablets, 240 mg (NSN 6505-01-271-7667)

Posted

August 05, 2026

Respond By

August 10, 2026

Identifier

SPE2DP-26-T-4480

NAICS

325412, 424210

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is soliciting quotations for Verapamil Hydrochloride Extended-Release Tablets, 240 mg, under NSN 6505-01-271-7667. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain, Pharmaceutical Field Support Activity - OEMs (Approved Manufacturers): - Cardinal Health 200, LLC - Glenmark Pharmaceuticals Inc., USA - Vendors (as OEMs): - Cardinal Health 200, LLC - Glenmark Pharmaceuticals Inc., USA - Products Requested: - Verapamil Hydrochloride Extended-Release Tablets, 240 mg - NSN: 6505-01-271-7667 - Part numbers: NDC00025-1891-32 (Cardinal Health 200, LLC), NDC68462-0260-01 (Glenmark Pharmaceuticals Inc., USA) - Quantity: 2 bottles (each bottle contains 100 tablets) - Notable Requirements: - Minimum shelf life of 31 months upon receipt (out of a 36-month total shelf life) - Delivery required within 20 calendar days of award (FOB destination) - Compliance with medical packaging and marking standards - Must comply with domestic sourcing laws - Prohibition on covered defense telecommunications equipment

Description

VERAPAMIL HYDROCHLO (QTY: 2, NSN: 6505-01-271-7667, Purchase Request: 7015502340) Approved Sources: - CAGE: 07TA6, Part No: NDC00025-1891-32, Company: CARDINAL HEALTH 200, LLC - CAGE: 7A4E3, Part No: NDC68462-0260-01, Company: GLENMARK PHARMACEUTICALS INC., USA

View original listing